3.51
price up icon11.43%   0.36
after-market 시간 외 거래: 3.52 0.01 +0.28%
loading

Cardiff Oncology Inc 주식(CRDF)의 최신 뉴스

pulisher
Jun 18, 2025

Cardiff Oncology (CRDF) Stock Reacts to Delayed Clinical Data Up - GuruFocus

Jun 18, 2025
pulisher
Jun 18, 2025

CRDF Set to Release Key Clinical Data Amid Leadership Changes | CRDF Stock News - GuruFocus

Jun 18, 2025
pulisher
Jun 18, 2025

Cardiff Oncology (CRDF) Welcomes New Chief Medical Officer | CRD - GuruFocus

Jun 18, 2025
pulisher
Jun 17, 2025

Cardiff Oncology (CRDF) Shares Drop 11% After Leadership Change - GuruFocus

Jun 17, 2025
pulisher
Jun 17, 2025

Cardiff Oncology appoints Dr. Roger Sidhu as Chief Medical Officer - MarketScreener

Jun 17, 2025
pulisher
Jun 17, 2025

Cardiff Oncology stock falls as new medical chief named (CRDF) - Seeking Alpha

Jun 17, 2025
pulisher
Jun 17, 2025

Cardiff Oncology Appoints Dr. Roger Sidhu as Chief Medical - GlobeNewswire

Jun 17, 2025
pulisher
Jun 17, 2025

Cardiff Oncology Names New Chief Medical Officer - marketscreener.com

Jun 17, 2025
pulisher
Jun 17, 2025

Cardiff Oncology Appoints Dr. Roger Sidhu as Chief Medical Offic - GuruFocus

Jun 17, 2025
pulisher
Jun 17, 2025

Cardiff Oncology appoints Roger Sidhu as new Chief Medical Officer - Investing.com

Jun 17, 2025
pulisher
Jun 17, 2025

Bank of America Corp DE Sells 11,352 Shares of Cardiff Oncology, Inc. (NASDAQ:CRDF) - Defense World

Jun 17, 2025
pulisher
Jun 10, 2025

Two Sigma Investments LP Trims Stake in Cardiff Oncology, Inc. (NASDAQ:CRDF) - Defense World

Jun 10, 2025
pulisher
Jun 09, 2025

Two Sigma Advisers LP Trims Stake in Cardiff Oncology, Inc. (NASDAQ:CRDF) - Defense World

Jun 09, 2025
pulisher
Jun 05, 2025

ProShare Advisors LLC Acquires New Shares in Cardiff Oncology, Inc. (NASDAQ:CRDF) - Defense World

Jun 05, 2025
pulisher
Jun 04, 2025

Cardiff Oncology, Inc. (CRDF) Reports 40% Response Rate in mTNBC Trial of Onvansertib + Paclitaxel - MSN

Jun 04, 2025
pulisher
Jun 03, 2025

Nuveen Asset Management LLC Acquires 248,850 Shares of Cardiff Oncology, Inc. (NASDAQ:CRDF) - Defense World

Jun 03, 2025
pulisher
Jun 03, 2025

Deutsche Bank AG Acquires Shares of 49,566 Cardiff Oncology, Inc. (NASDAQ:CRDF) - Defense World

Jun 03, 2025
pulisher
Jun 03, 2025

Millennium Management LLC Buys 288,259 Shares of Cardiff Oncology, Inc. (NASDAQ:CRDF) - Defense World

Jun 03, 2025
pulisher
Jun 03, 2025

Cardiff Oncology (CRDF) Reports Promising Phase 1b Trial Results for Breast Cancer Treatment | CRDF Stock News - GuruFocus

Jun 03, 2025
pulisher
Jun 02, 2025

Cardiff Oncology Announces Positive Data From Investigator-Initiated Trial Of Onvansertib In Combination With Paclitaxel - marketscreener.com

Jun 02, 2025
pulisher
Jun 02, 2025

Cardiff Oncology's Phase 1b Trial for Breast Cancer Treatment Shows 40% Objective Response Rate - marketscreener.com

Jun 02, 2025
pulisher
Jun 02, 2025

Cardiff Oncology reports positive trial results for breast cancer treatment By Investing.com - Investing.com Nigeria

Jun 02, 2025
pulisher
Jun 02, 2025

Cardiff Oncology reports positive trial results for breast cancer treatment - Investing.com

Jun 02, 2025
pulisher
Jun 02, 2025

Cardiff Oncology Announces Positive Data from Investigator-Initi - GuruFocus

Jun 02, 2025
pulisher
Jun 02, 2025

Cardiff Oncology Announces Positive Data from Investigator-Initiated Trial of Onvansertib in Combination with Paclitaxel in Metastatic Triple-Negative Breast Cancer Presented at ASCO 2025 - The Manila Times

Jun 02, 2025
pulisher
Jun 02, 2025

Cardiff Oncology Reports 40% Objective Response Rate in Phase 1b Trial of Onvansertib and Paclitaxel for Metastatic Triple-Negative Breast Cancer - Nasdaq

Jun 02, 2025
pulisher
Jun 02, 2025

Clinical Trial Success: Cardiff Oncology's New Drug Shows 40% Response Rate in Aggressive Breast Cancer - Stock Titan

Jun 02, 2025
pulisher
May 30, 2025

Cardiff Oncology (CRDF) Emerges as a Prime M&A Target - GuruFocus

May 30, 2025
pulisher
May 30, 2025

SA Asks: Which oncology companies are attractive M&A targets? - Seeking Alpha

May 30, 2025
pulisher
May 28, 2025

Northern Trust Corp Raises Stock Holdings in Cardiff Oncology, Inc. (NASDAQ:CRDF) - Defense World

May 28, 2025
pulisher
May 26, 2025

Cardiff Oncology Reports Second Quarter 2023 Results and Provides Business Update - Seeking Alpha

May 26, 2025
pulisher
May 20, 2025

The Manufacturers Life Insurance Company Makes New $67,000 Investment in Cardiff Oncology, Inc. (NASDAQ:CRDF) - Defense World

May 20, 2025
pulisher
May 19, 2025

Price T Rowe Associates Inc. MD Has $67,000 Stock Holdings in Cardiff Oncology, Inc. (NASDAQ:CRDF) - Defense World

May 19, 2025
pulisher
May 16, 2025

13,124 Shares in Cardiff Oncology, Inc. (NASDAQ:CRDF) Bought by Voya Investment Management LLC - Defense World

May 16, 2025
pulisher
May 15, 2025

Cardiff Oncology Reports Increased Losses Amid Rising R&D Costs - TipRanks

May 15, 2025
pulisher
May 15, 2025

Raymond James Financial Inc. Purchases New Shares in Cardiff Oncology, Inc. (NASDAQ:CRDF) - Defense World

May 15, 2025
pulisher
May 14, 2025

Cardiff Oncology (CRDF) Upgraded to Buy: Here's What You Should Know - Nasdaq

May 14, 2025
pulisher
May 14, 2025

Cardiff Oncology: Buying The First-Line Onvansertib Strategy (NASDAQ:CRDF) - Seeking Alpha

May 14, 2025
pulisher
May 12, 2025

Barclays PLC Purchases 9,507 Shares of Cardiff Oncology, Inc. (NASDAQ:CRDF) - Defense World

May 12, 2025
pulisher
May 11, 2025

Wells Fargo & Company MN Purchases 8,851 Shares of Cardiff Oncology, Inc. (NASDAQ:CRDF) - Defense World

May 11, 2025
pulisher
May 10, 2025

Cardiff Oncology First Quarter 2025 Earnings: Revenues Beat Expectations, EPS Lags - Yahoo

May 10, 2025
pulisher
May 10, 2025

Mariner LLC Makes New $61,000 Investment in Cardiff Oncology, Inc. (NASDAQ:CRDF) - Defense World

May 10, 2025
pulisher
May 09, 2025

Cardiff Oncology stock target raised to $18 by H.C. Wainwright - Investing.com Canada

May 09, 2025
pulisher
May 09, 2025

Cardiff Oncology (CRDF) Gains Analyst Confidence with Price Target Increase | CRDF Stock News - GuruFocus

May 09, 2025
pulisher
May 09, 2025

Cardiff Oncology (CRDF) Price Target Increased by Analyst | CRDF Stock News - GuruFocus

May 09, 2025
pulisher
May 09, 2025

Cardiff Oncology: Q1 Earnings Snapshot - New Haven Register

May 09, 2025
pulisher
May 09, 2025

Cardiff Oncology earnings missed by $0.01, revenue topped estimates - Investing.com Canada

May 09, 2025
pulisher
May 08, 2025

Promising Clinical Trial Developments Drive Buy Rating for Cardiff Oncology - TipRanks

May 08, 2025
pulisher
May 08, 2025

Cardiff Oncology (CRDF) Reports Strong Q1 Revenue and Advances Cancer Therapy | CRDF Stock News - GuruFocus

May 08, 2025
pulisher
May 08, 2025

Cardiff Oncology (CRDF) Reports Q1 Loss, Lags Revenue Estimates - Yahoo Finance

May 08, 2025
pulisher
May 08, 2025

Cardiff Oncology Q1 2025 Earnings: EPS Misses at -$0.20, Revenue Slightly Beats at $0.11 Million - GuruFocus

May 08, 2025
pulisher
May 08, 2025

Cardiff Oncology Reports First Quarter 2025 Results and Provides Business Update - GlobeNewswire

May 08, 2025
$20.74
price up icon 0.39%
$35.88
price down icon 0.42%
$21.20
price down icon 0.38%
$97.62
price down icon 3.00%
$107.51
price up icon 0.98%
biotechnology ONC
$245.16
price up icon 1.28%
자본화:     |  볼륨(24시간):